App Description

FEBS Letters brings together the most important developments in the molecular biosciences, providing an international forum for Minireviews, Research Letters and Hypotheses that merit urgent publication.

Enjoy an entirely new browsing and reading experience with the app, and keep up to date with the most important developments in this subject area:
- Stay current with the latest articles through Early View
- Receive alerts when new issues are available
- Download articles and issues for offline perusal
- Save your favourite articles for quick and easy access, including offline
- Browse issues before you decide to download them
- Dynamic References show references in context
- Share article abstracts, figures or tables via email

CURRENT SUBSCRIBERS to FEBS Letters can “pair” their device with their personal or institutional subscription to enjoy full access in this iPad edition.

SUBSCRIBE IN THE APP: Annual Subscriptions (6 issues) for the iPad-only edition are available for $999.99 (US) per year. Payment is charged to your iTunes account after confirmation of purchase. FEBS Letters subscriptions automatically renew within 24 hours of the end of your subscription period for $999.99 (US) unless auto-renew is turned off at least 24 hours before the end of the subscription period. To turn off auto-renew, go to your iTunes account settings after purchase. Note that subscriptions cannot be cancelled during the term of the subscription, but you can still turn off auto-renew to prevent automatic renewal of your subscription. Note that any unused portion of a free trial period, if offered, will be forfeited when you purchases a subscription.

iPhone Screenshots

(click to enlarge)

FEBS Letters screenshot 1 FEBS Letters screenshot 2 FEBS Letters screenshot 3 FEBS Letters screenshot 4 FEBS Letters screenshot 5

iPad Screenshots

(click to enlarge)

FEBS Letters screenshot 6 FEBS Letters screenshot 7 FEBS Letters screenshot 8 FEBS Letters screenshot 9 FEBS Letters screenshot 10

App Changes

  • June 30, 2016 Initial release